Pilar Andaluz - Concepedia

Author

Pilar Andaluz

Centre for Biomedical Network Research on Rare Diseases

Also Known As

Andaluz, P., P. Andaluz, Pilar Andaluz

Publications

861

Citations

H-Index

Concepts

All Affiliations

Centre for Biomedical Network Research on Rare Diseases Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Instituto de Salud Carlos III Hospital Universitari Germans Trias i Pujol

About

Pilar Andaluz is an author at Centre for Biomedical Network Research on Rare Diseases specializing in developmental biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	167
2	Cell Biology	4	4	167
3	Endocrinology	2	2	49
4	Health Sciences	1	1	62
5	Regenerative Medicine	1	1	62

Pilar Andaluz

Publications

755

Citations

H-Index

Page 1

	Year	Citations
Novel (60%) and Recurrent (40%) Androgen Receptor Gene Mutations in a Series of 59 Patients with a 46,XY Disorder of Sex Development Laura Audí, Mónica Fernández‐Cancio, Antonio Carrascosa, The Journal of Clinical Endocrinology & Metabolism	2010	145
Ten Novel Mutations in the NR5A1 Gene Cause Disordered Sex Development in 46,XY and Ovarian Insufficiency in 46,XX Individuals Núria Camats, Amit V. Pandey, Mónica Fernández‐Cancio, The Journal of Clinical Endocrinology & Metabolism	2012	132
The d3/fl-Growth Hormone (GH) Receptor Polymorphism Does Not Influence the Effect of GH Treatment (66 μg/kg per Day) or the Spontaneous Growth in Short Non-GH-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study in 170 Spanish Patients Antonio Carrascosa, Cristina Estéban, R. Espadero, The Journal of Clinical Endocrinology & Metabolism	2006	81
Vascular Endothelial Growth Factor Is Expressed in Human Fetal Growth Cartilage Marta García‐Ramírez, Núria Torán, Pilar Andaluz, Journal of Bone and Mineral Research Regenerative MedicineDevelopmental BiologyAngiogenesisEndothelial CellsHuman Growth	2000	62
Decreased cell proliferation and higher oxidative stress in fibroblasts from Down Syndrome fetuses. Preliminary study Amparo Gimeno, Jose Luis García‐Giménez, Núria Torán, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Down SyndromeDevelopmental BiologyCell ProliferationHigher Oxidative StressMaternal-fetal Medicine	2013	56
The Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism Did Not Influence Growth Response to Growth Hormone Therapy over Two Years in Prepubertal Short Children Born at Term with Adequate Weight and Length for Gestational Age Antonio Carrascosa, Mónica Fernández‐Cancio, Cristina Estéban, The Journal of Clinical Endocrinology & Metabolism	2007	43
Growth Hormone (GH) Dose, But Not Exon 3-Deleted/Full-Length GH Receptor Polymorphism Genotypes, Influences Growth Response to Two-Year GH Therapy in Short Small-for-Gestational-Age Children Antonio Carrascosa, Laura Audí, Cristina Estéban, The Journal of Clinical Endocrinology & Metabolism	2007	42
SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation Mónica Fernández‐Cancio, Laura Audí, Pilar Andaluz, International Journal of Andrology	2011	39
Familial short stature and intrauterine growth retardation associated with a novel mutation in the <scp>IGF</scp>‐<scp>I</scp> receptor (<i><scp>IGF1R</scp></i>) gene José Ignacio Labarta, E Barrio, Laura Audí, Clinical Endocrinology	2012	30
Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH–IGF) axis gene expression in human fetal epiphyseal chondrocytes Mónica Fernández‐Cancio, Antonio Carrascosa, Núria Torán, Growth Hormone & IGF Research Developmental BiologyGrowth HormoneBone Morphogenic ProteinHuman GrowthPhysiology	2008	30

Page 1